Submissions to 2011/2012 Code Review
- Amgen
410k - AstraZeneca 107k
- Atlantis Healthcare 79k
- Australia and New Zealand Bone and Mineral Society 21k
- Australian Medical Association 84k
- Australian Society of Anaesthetists 40k
- Baxter Healthcare 28k
- Brand Promotions 197k
- Centre for Health Initiatives, The University of Wollongong 351k
- Consumers Health Forum 238k
- Council of Australian Therapeutic Advisory Groups 346k
- CSL 176k
- Department of Health, ACT 25k
- Department of Health, NSW 131k
- Department of Health, South Australia 407k
- Department of Health, Victoria 80k
- Department of Health, Western Australia 161k
- Dr Agnes Vitry 134k
- Dr Ken Harvey 186k
- Electronic Distribution Working Group 491k
- Eli Lilly Australia 1537k
- Elsevier 200k
- Ferring Pharmaceuticals 20k
- GlaxoSmithKline Australia 140k
- Ian Kerridge 137k
- Lundbeck Australia 44k
- Medical Technology Association of Australia 169k
- Mental Health Council of Australia 72k
- Merck Serono 19k
- Merck Sharp and Dohme 69k
- Mr Henry Ko 166k
- Mr Russell Edwards 143k
- National Medicines Policy Committee 20k
- National Prescribing Service 103k
- Novartis Pharmaceuticals Australia 88k
- NSW Therapeutic Advisory Group 242k
- Pfizer Australia 1019k
- Pharmaceutical Society of Australia 34k
- Roche Products 282k
- Royal Australian and New Zealand College of Psychiatrists 32k
- Royal Australian College of Physicians 58k
- Royal Australian College of Surgeons 60k
- Royal College of Dermatologists 13k
- Sanofi 1024k
- Servier Laboraties (Aust) Pty Ltd 173k
- South East Sydney Local Health District Drug and QUM Committee 41k
- The Australian Medical Association 78k
- The Communications Council 69k
- The Department of Health and Ageing 65k
- UBM Medica Australia 142k
- Wolters Kluwer Pharma Solutions 46k
Page updated: March 2012